Matthew Stanton
Stock Analyst at Jefferies
(0.39)
# 3,998
Out of 4,737 analysts
5
Total ratings
33.33%
Success rate
-15.8%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $8.57 | -6.65% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.83 | +77.60% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $27.47 | -19.91% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $53.98 | +18.56% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $8.57
Upside: -6.65%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.83
Upside: +77.60%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $27.47
Upside: -19.91%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $53.98
Upside: +18.56%